Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
09:08am, Tuesday, Aug 12, 2025
Hour Loop, Inc. (NASDAQ: HOUR) - Quick internal read
What's happening inside: Hour Loop remains an Amazon‑centric e‑commerce seller (≈99% of sales through Amazon). Management is prioritizing margin stability and inventory coverage amid tariff uncertainty - they significantly increased inventory o...
09:07am, Tuesday, Aug 12, 2025
Empery Digital Inc. (NASDAQ: VLCN) - quick read
Short summary: management has executed multiple equity raises, completed a strategic pivot to a Bitcoin treasury strategy in July 2025 and materially strengthened liquidity, but the core EV business still produces negative gross margins, negative op...
09:06am, Tuesday, Aug 12, 2025
Snapshot
Hydrofarm Holdings Group, Inc. (NASDAQ: HYFM) - Q2 2025 10‑Q: the company is executing a second restructuring, shrinking product lines and footprint, managing debt and burning cash while revenue and margins remain pressured by industry oversupply.
Key facts & figures (reported)
* Net sal...
09:05am, Tuesday, Aug 12, 2025
Snapshot - Ondas Holdings Inc. (ONDS) (NASDAQ)
Quick read - what's happening inside the company
* OAS (the drone/Autonomous Systems unit) is carrying the revenue recovery: multi‑drone product sales and subscriptions drove Q2 momentum. OAS accounted for $6,093,929 of Q2 revenue vs. Ondas Networks ...
09:04am, Tuesday, Aug 12, 2025
Atossa Therapeutics, Inc. (NASDAQ: ATOS)
Quick read: the company is a clinical‑stage biopharma advancing oral (Z)-endoxifen. It has encouraging clinical signals across multiple trials but is still pre‑revenue, burning cash, facing patent challenges and a Nasdaq minimum‑bid compliance notice.
Key ...
09:03am, Tuesday, Aug 12, 2025
Xtant Medical Holdings, Inc. (NYSE: XTNT)
Quick read - what's happening inside
- Management is executing product / licensing deals and preparing portfolio disposals: license revenue recognized in 2025 and pending asset and equity sales announced July 7, 2025 (Coflex/CoFix assets sale for $17.5M a...
09:02am, Tuesday, Aug 12, 2025
Scienture Holdings, Inc. (NASDAQ: MEDS) - Quick take
Inside the company: management has completed a portfolio reshuffle - selling legacy subsidiaries (IPS/Softell/Bonum) for a $5,000,000 promissory note (now assigned to a related party), completed the July 2024 acquisition of Scienture and is piv...
09:01am, Tuesday, Aug 12, 2025
Abacus Global Management, Inc. (NASDAQ: ABLLL) - Quick take
Inside the company: Abacus is scaling through acquisitions (Carlisle, FCF, NIB) and expansion of its three segments - Asset Management, Life Solutions and Technology Services - and is showing a clear revenue and profitability step-up in ...
08:12am, Tuesday, Aug 12, 2025
U.S. Energy Corp. (NASDAQ: USEG) - concise take on what's happening inside the company and what the income statement shows.
Quick summary: Management is shifting focus toward industrial gas (Kevin Dome acquisition), funded by an $11.9M equity raise in January 2025. Meanwhile oil & gas revenues an...
08:11am, Tuesday, Aug 12, 2025
Snapshot - Optex Systems Holdings, Inc. (OTCBB: OPXS)
Here's what's happening inside the company and what the income statement is telling investors - straight to the point.
Key facts & numbers
* Revenue (3 months ended 6/29/2025): $11,110,000 - up 22.6% vs prior-year quarter.
* Revenue (9 months)...
08:11am, Tuesday, Aug 12, 2025
Snapshot - Adverum Biotechnologies, Inc. (NASDAQ: ADVM)
What's happening inside the company
- Advancing lead gene‑therapy candidate ixoberogene soroparvovec (Ixo‑vec): ARTEMIS Phase 3 initiated Feb 2025; enrollment expected complete Q1 2026; top‑line ARTEMIS data expected H1 2027.
- LUNA Phase 2 ...
08:09am, Tuesday, Aug 12, 2025
Korro Bio, Inc. (NASDAQ: FREQ) - quick financial & operational read
Context: The company (formerly Frequency Therapeutics) is a clinical‑stage RNA‑editing biotech that completed a reverse merger in Nov 2023. This note summarizes what's happening internally and the main positives and negatives fro...
08:09am, Tuesday, Aug 12, 2025
Centessa Pharmaceuticals plc (NASDAQ: CNTA) - quick inside look
What's happening inside
* Management has pivoted capital and focus toward its OX2R (orexin receptor 2) agonist franchise (ORX750, ORX142, ORX489) after discontinuing several prior programs (SerpinPC and LB101).
* The company out‑lice...
08:08am, Tuesday, Aug 12, 2025
Climb Bio, Inc. (NASDAQ: ELYM)
Short take - Climb Bio is a clinical‑stage immunology biotech that scaled materially in mid‑2024 (Tenet acquisition) and early‑2025 (Mabworks license). Financials reflect the shift from a one‑time acquisition charge in 2024 to active clinical and licensing spend in ...
08:07am, Tuesday, Aug 12, 2025
Snapshot - Passage Bio, Inc. (PASG) (NASDAQ)
What's happening inside: the company executed a major restructuring in Jan 2025 (≈55% workforce reduction) and ceased Hopewell lab operations, out‑licensed several pediatric lysosomal programs to Gemma, and is concentrating resources on its lead clinic...
